NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].
Show detailsOVERVIEW
Introduction
Loperamide is synthetic opioid that primarily affects opiate receptors in the intestine and is used to treat diarrhea. Loperamide has not been linked to serum enzyme elevations during therapy or to clinically apparent liver injury.
Background
Loperamide (loe per’ a mide) is a synthetic piperidine derivative that acts as a mild opiate receptor agonist (predominant µ type receptors), but is used largely for the treatment of diarrhea rather than pain. Loperamide is not structurally related to morphine or codeine and has minimal or no euphoric or analgesic effects, apparently because it is poorly absorbed orally and is actively transported out of the central nervous system. Loperamide acts as a potent opiate agonist in the intestine and reduces intestinal motility, causing a slowing of intestinal transport and increased resorption of water and electrolytes, actions that are helpful in treating diarrhea. Loperamide was approved for use in the United States in 1976 and is still widely used to treat acute diarrhea caused by gastroenteritis, as well as the chronic diarrhea of inflammatory bowel disease. Loperamide is available as tablets and capsules of 2 mg and solution of 1 mg/5 mL generically and under the brand name Imodium. The usual dose of loperamide in adults is 4 mg initially, followed by 2 mg after each unformed stool, not to exceed 16 mg daily. Side effects of loperamide include abdominal bloating and pain, nausea and vomiting and constipation. Rare side effects include hypersensitivity reactions and paralytic ileus. Loperamide is not classified as a controlled substance and several formulations are available without prescription.
Hepatotoxicity
As with most opiates in current use, therapy with loperamide has not been linked to serum enzyme elevations. There have been no convincing cases of idiosyncratic acute, clinically apparent liver injury attributed to either agent. The reason for its lack of hepatotoxicity may relate to the low doses used and lack of significant systemic absorption. What loperamide is absorbed is metabolized in the liver.
References on the safety and potential hepatotoxicity of loperamide are given in the overview section of the Opioids. Last updated: 20 May 2019
Drug Class: Gastrointestinal Agents; Opioids
PRODUCT INFORMATION
REPRESENTATIVE TRADE NAMES
Loperamide – Generic, Imodium®
DRUG CLASS
Gastrointestinal Agents; Opioids
Product labeling at DailyMed, National Library of Medicine, NIH
CHEMICAL FORMULA AND STRUCTURE
DRUG | CAS REGISTRY NO. | MOLECULAR FORMULA | STRUCTURE |
---|---|---|---|
Loperamide | 53179-11-6 | C29-H33-Cl-N2-O2 |
- Review Diphenoxylate.[LiverTox: Clinical and Researc...]Review Diphenoxylate.. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012
- Opiate-induced constipation related to activation of small intestine opioid μ2-receptors.[World J Gastroenterol. 2012]Opiate-induced constipation related to activation of small intestine opioid μ2-receptors.Chen W, Chung HH, Cheng JT. World J Gastroenterol. 2012 Mar 28; 18(12):1391-6.
- Autoradiographic demonstration of [3H] loperamide binding to opioid receptors in rat and human small intestine.[Prog Clin Biol Res. 1990]Autoradiographic demonstration of [3H] loperamide binding to opioid receptors in rat and human small intestine.Dashwood MR, Sykes RM, Thomson CS. Prog Clin Biol Res. 1990; 328:165-9.
- Review Loperamide. Survey of studies on mechanism of its antidiarrheal activity.[Dig Dis Sci. 1993]Review Loperamide. Survey of studies on mechanism of its antidiarrheal activity.Awouters F, Megens A, Verlinden M, Schuurkes J, Niemegeers C, Janssen PA. Dig Dis Sci. 1993 Jun; 38(6):977-95.
- Loperamide effects on hepatobiliary function, intestinal transit and analgesia in mice.[Life Sci. 1994]Loperamide effects on hepatobiliary function, intestinal transit and analgesia in mice.Hurwitz A, Sztern MI, Looney GA, Ben-Zvi Z. Life Sci. 1994; 54(22):1687-98.
- Loperamide - LiverToxLoperamide - LiverTox
Your browsing activity is empty.
Activity recording is turned off.
See more...